Fact sheet: BlackRock GF Wld Hlt Sci

Fund information

Fund name
BlackRock GF World Healthscience A2 USD
Fund company manager
BlackRock (Luxembourg) S.A.
Fund type
SIB
Fund manager
Thomas Callen
since 01/04/2011
Fund objective
The Fund aims to maximise the return on your investment through a combination of capital growth and income on the Fund’s assets. The Fund invests globally at least 70% of its total assets in the shares of companies the main business of which is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology.
Benchmark
MSCI World Healthcare
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

10.19 %

1 Year rank in sector

10/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 3.2 b

FE Risk score

130

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    76.14%
  • Switzerland
    5.87%
  • UK
    4.65%
  • France
    3.51%
  • Japan
    2.87%
  • Pharmaceuticals
    36.2%
  • Health Care
    21.77%
  • Biotechnology/Medical
    20.53%
  • Healthcare & Medical Products
    19.34%
  • Money Market
    1.97%
  • US Equities
    76.14%
  • Swiss Equities
    5.87%
  • UK Equities
    4.65%
  • French Equities
    3.51%
  • Japanese Equities
    2.87%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund2.57 %9.11 %10.19 %22.04 %101.14 %
Sector2.44 %5.7 %6.98 %21.14 %97.17 %
Rank within sector18 / 3010 / 3010 / 2911 / 279 / 23
Quartile th3 rd2 nd2 nd2 nd2 nd

Calendar performance

YTD-20172016201520142013
Fund19.22 %-8.02 %4.56 %24.4 %43.09 %
Sector15.5 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector12 / 2911 / 2920 / 2717 / 2410 / 23
Quartile th2 nd2 nd3 rd3 rd2 nd

Risk statistics

Alpha0.8
Beta0.83
Sharpe0.26
Volatility13.37
Tracking error4.92
Information ratio-0.07
R-Squared0.91

Price movement

52 week high39.24
52 week low31.57
Current bid price0
Current offer price0
Current mid price38.7

Holdings by region

  • 76.14% USA
  • 5.87% Switzerland
  • 4.65% UK
  • 3.51% France
  • 2.87% Japan
  • 2.72% Germany
  • 1.97% Money Market
  • 1.55% Denmark
  • 0.25% Australia
  • 0.16% British Virgin Islands

Holdings by sector

  • 36.2% Pharmaceuticals
  • 21.77% Health Care
  • 20.53% Biotechnology/Medical
  • 19.34% Healthcare & Medical Products
  • 1.97% Money Market
  • 0.19% Consumer Services

Holdings by asset type

  • 76.14% US Equities
  • 5.87% Swiss Equities
  • 4.65% UK Equities
  • 3.51% French Equities
  • 2.87% Japanese Equities
  • 2.72% German Equities
  • 1.97% Money Market
  • 1.55% Danish Equities
  • 0.25% Australian Equities
  • 0.16% American Emerging Equities

Individual holdings

  • 5.87% UNITEDHEALTH GROUP INC
  • 3.84% JOHNSON & JOHNSON
  • 3.74% MEDTRONIC INC
  • 3.29% ROCHE HLDG AG
  • 3.27% SANOFI
  • 3.12% CELGENE CORP
  • 2.79% STRYKER CORP
  • 2.57% ASTRAZENECA PLC
  • 2.57% HUMANA INC
  • 2.57% NOVARTIS AG